Skip to content

Clinical trials

Completed Phase 1 Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 1 Status: Completed Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20031
20043
20052
200610
20074
20085
200911
20104
20112
20124
20148
20156
20162
201710
20185
20193
20203
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institutes of Health Clinical Center (CC)7
National Cancer Institute (NCI)6
M.D. Anderson Cancer Center4
Celldex Therapeutics3
Memorial Sloan Kettering Cancer Center3
Xencor, Inc.3
Novartis Pharmaceuticals2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
University of Chicago2
AEterna Zentaris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms100
Carcinoma, Hepatocellular42
Pancreatic Neoplasms24
Stomach Neoplasms24
Colorectal Neoplasms23
Breast Neoplasms22
Ovarian Neoplasms20
Kidney Neoplasms18
Lung Neoplasms17
Neoplasm Metastasis17

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.